Department of Clinical Oncology
Chinese University of Hong Kong
Research Interest :
Breast cancer, Liver cancer, Hepatitis B virus-related
complications during cancer treatment
Selected Publications on Women's Health :
ˇ@
1.
Yeo, W.,
Mo, F.K.F., Suen, J.J.S., Ho, W.M., Chan, S.L., Lau,
W., Koh, J., Yeung, W.K., Kwan, W.H., Lee, K.K.C., Mok,
T.S.K., Poon, A.N.Y., Lam, K.C., Hui, E.K., Zee., B.
(2009) A randomized study of aprepitant, ondansetron
and dexamethasone for chemotherapy-induced nausea and
vomiting in Chinese breast cancer patients receiving
moderately emetogenic chemotherapy. Breast Cancer
Research and Treatment 113(3): 529. <Enter>
2.
Wong, N., Yeo, W., Wong, N.L.Y.,
Wong, W.L., Chan., K.Y.Y., Mo, F.K.F.,
Koh, J.,
Chan, L., Chan, A.T.C., Lai, P.B.S.,
Johnson, P.J., To, K.F. (2009) TOP2A Expression in
Hepatocellular Carcinoma Correlates with Early Age
Onset, Shorter Survival but can Enhance Chemo-sensitisation
by Etoposide. International journal of cancer 124(3):
644.
3.
Bernhard, J., Zahrieh, D., Zhang, J.J.,
Martinelli, G., Basser, R., Hu¨rny, C., Forbes, J.F.,
Aebi, S., Yeo, W., Thu¨rlimann, B., Green, M.D.,
Colleoni, M., Gelber, R.D., Castiglione-Gertsch, M.,
Price, K.N., Goldhirsch, A., Coates, for the
International Breast Cancer Study Group (IBCSG). (2008)
Quality of life and quality-adjusted survival (Q-TWiST)
in patients receiving dose-intensive or standard dose
chemotherapy for high-risk primary breast cancer.
British Journal of Cancer 98: 25. <Enter>
4.
Chan, H.L.Y., Tse, C.H., Mo, F.K.F.,
Wong, V.W.S., Wong, G.L.H., Chan, S.L., Yeo, W.,
Sung, J.J.Y., Mok, T.S.K. (2008) High viral load and
hepatitis b virus subgenotype Ce are associated with
increased risk of hepatocellular carcinoma. Journal of
Clinical Oncology 26(2):
177. <Enter>
5.
Qiu, G.H., Salto-Tellez, M., Ross, J.A.,
Yeo, W., Cui, Y., Wheelhouse, N., Chen, G.G.,
Harrison, D., Lai, P., Tao, Q., Hooi, S.C. (2008) The
tumor suppressor gene DLEC1 is frequently silenced by
DNA methylation in hepatocellular carcinoma and induces
G1 arrest in cell cycle. Journal of Hepatology
48(3):
433. <Enter>
6.
Yu, S.C.H., Leung, T., Lau, W., Lee, N.,
Hui, E.P., Yeo, W., Lai, P.S.B., Mok, T.S.K.
(2008) A comparison of three transarterial lipiodol-based
formulations for hepatocellular carcinoma: in vivo
biodistribution study in humans. CardioVascular and
Interventional Radiology 31(2):
289. <Enter>
7.
Yu S.C., Hui E.P.,
Wong J, Wong H, Mo F, Ho S.S, Wong Y.Y, Yeo W,
Lai P.B, Chan A.T, Mok T.S. (2008)
Transarterial ethanol ablation of
hepatocellular carcinoma with lipiodol ethanol mixture:
phase II study. Journal of Vascular and Interventional
Radiology19(1):
95 <Enter>
8.
Mak, S.S., Yeo, W., Lee, Y.M.,
Mo, K.F., Tse, K.Y., Tse, S.M., Ho, F.P., Kwan, W.H.
(2008) Predictors of lymphedema in patients with breast
cancer undergoing axillary lymph node dissection in
Hong Kong.
Nursing Research57(6): 416. <Enter>
9.
Yeo W, Boyer M, Chung H.C, Ong
S.Y.K, Lim R, Zee B, Ma B, Lam K.C, Mo F.K.F, Ng E.K.W,
Ho R, Clarke S, Roh J.K, Beale P, Rha S.Y, Jeung H.C,
Soo R, Goh B.C, Chan A.T.C. (2007) Irofulven as first
line therapy in recurrent or metastatic gastric cancer:
a phase II
multicenter study by the Cancer
Therapeutics Research Group
(CTRG). Cancer Chemotherapy and
Pharmacology 59: 295. <Enter>
10.
Mok, T.S.K., Yeo, W., Johnson,
P.J., Hui, P., Ho, W.M., Lam, K.C., Xu, M., Chak, K.,
Chan, A, Wong, H., Koh, J., Mo, F., Zee, B. (2007) A
Double-Blind Placebo-Controlled Randomized Study of
Chinese Herbal Medicine as Complimentary Therapy for
Reduction of Chemotherapy-Induced Toxicity. Ann Oncol
18: 768. <Enter>
Chan, S., Tam, W., Yeo, W., Yu,
M., Ng, D., Wong, A., Kwan, W., Yuen, P. (2007) A
randomised controlled trial of prophylactic
levonorgestrel intrauterine system in tamoxifen-treated
women. Journal of Obstetrics and
Gynaecology 114: 1510. <Enter>
13.
W Yeo , WH Kwan, PML Teo, S Nip, E Wong, LY Hin, PJ Johnson. Psychosocial impact of breast cancer surgeries in Chinese patients and their spouses. Psycho-Oncology 200 4 , 13:132-139.
14.
W Yeo , WM Ho, P Hui, PKS Chan, KC Lam, JJ Lee, PJ Johnson. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patient. Breast Cancer Research and Treatment 2004 ; 88: 209-215 .
15.
Chua MS, Mok TS, Kwan WH, Yeo W , Zee B. Knowledge, perceptions, and attitudes of Hong Kong Chinese women on screening mammography and early breast cancer management. Breast J. 2005 Jan-Feb;11(1):52-6.
16.
W. Yeo , W. M. Ho, P. Hui, K.C. Lam, B. Zee, W.H. Kwan, P.K.S. Chan, J.J. Lee, P.J. Johnson. Lamivudine can reduce hepatitis B reactivation in HBsAg seropositive breast cancer patients during chemotherapy. The 9 th Annual Symposium of the Hong Kong Cancer Institute. ˇ§Anti-Cancer Drug Development- From Bench to Bedside to Marketˇ¨, 19-20 March 2004 , abstract book, p39, #20.
17.
B Zee, W Yeo , MP Lai, C Koh, HM Chu. LM Lee . Chemotherapy-induced nausea affects patients' quality of life (QOL) more than chemotherapy-induced vomiting. The 9 th Annual Symposium of the Hong Kong Cancer Institute. ˇ§Anti-Cancer Drug Development- From Bench to Bedside to Marketˇ¨, 19-20 March 2004 , abstract book, p 40, #22.
18.
W. Yeo , W. M. Ho, P. Hui, K. C. Lam, B. Zee, W. H. Kwan, P. K. S. Chan, J. J. Lee, P. J. Johnson. Lamivudine for the prevention of hepatitis B reactivation in HBsAg cancer patients undergoing cytotoxic chemotherapy- A prospective study. 4th European Breast Cancer Conference, European Journal of Cancer 2004; 2(3): 142. 16-20 March 2004.
19.
RR Deuson, B Zee, T Mok, W Yeo , F Mo, A Lee. Impact of nausea and vomiting on quality pf life in patients receiving moderately to highly emetogenic chemotherapy in Hong Kong. ISOQOL 11th Annual Scientific Conference October 16-19, 2004, Hong Kong.
20.
W Yeo , W-L Wong, N Wong, B Law, GM Tse, S Zhong. High frequency of promoter hypermethylation of RASSF1A in tumour and peritumoral tissue of breast cancer. Pathology 2005, 37(2): 125-130.
21.
T.S.K. Mok, W. Yeo , P. Hui, W.M. Ho, K.C. Lam, Z.R. Pan, W.C. Au, M. Xu, T.C. Chan, K. Chak, P. Johnson, B Zee. A Double-blind Placebo-control Randomized Study of the Efficacy of Chinese Herbal Medicine (CHM) in Reduction of Cytotoxic Chemotherapy-induced toxicity. Proceedings of American Society of Clinical Oncology 2005; 23 (16S pt 1): 768s.
22.
A Chang, J Beith, W Yeo , M Boyer, J Wong, S E Lim, A Chan. Phase I/II Study of Weekly Paclitaxel (P), UFT and Leucovorin in Patients with Metastatic Breast Cancer (MBC). A Cancer Therapeutic Research Group (CTRG) study. Proceedings of American Society of Clinical Oncology 2005; 23 (16S pt 1): 59s.
